Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug ...

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Ozempic, a drug initially used to treat type 2 diabetes, is gaining attention for its weight loss benefits and potential to reduce Alzheimer's risk. However, it comes with side effects like nausea, ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

MONDAY, Nov. 11, 2024 (HealthDay News) -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...